Human Vaccines & Immunotherapeutics (Nov 2021)

Determinants of COVID-19 vaccine acceptance and hesitancy: a cross-sectional study in Saudi Arabia

  • Amar Ibrahim Omer Yahia,
  • Abdullah Mohammed Alshahrani,
  • Wael Gabir H. Alsulmi,
  • Mohammed Mesfer M. Alqarni,
  • Tamim Khalid Abdullah Abdulrahim,
  • Waleed Faya H Heba,
  • Turki Ayidh A. Alqarni,
  • Khalid Ali Z Alharthi,
  • Abdullah Ali A. Buhran

DOI
https://doi.org/10.1080/21645515.2021.1950506
Journal volume & issue
Vol. 17, no. 11
pp. 4015 – 4020

Abstract

Read online

Several COVID-19 vaccines have been developed in unprecedented time by research centers and pharmaceutical companies. This study aimed to determine COVID-19 vaccine acceptance and hesitancy rates and investigated the factors that influence vaccine acceptance and hesitancy. A cross-sectional research was conducted among adults in Saudi Arabia between January and March 2021 to determine willingness to receive a COVID-19 vaccine. A self-administered questionnaire was designed to explore the participants’ COVID-19 vaccine acceptance and hesitancy. Categorical variables are described by frequency and percentage. A cross-tabulation analysis using the chi-squared test was performed to find associations between sociodemographic characteristics and vaccine acceptance and hesitancy. Logistic regression analysis was performed for variables that were found to be significant by the chi-squared test. A descriptive analysis of the 531 participants showed that 61.8% were willing to get the COVID-19 vaccine, while 38.2% were not. COVID-19 vaccine hesitancy was higher among women (44.9%), those 34–49 years of age (47.9%), those who were married (41.9%), employed (39.7%), had lower educational attainment (40%), and urban dwellers (40.8%). The main reason for COVID-19 vaccine acceptance was to protect oneself and others, while concerns about vaccine safety were the main reason for vaccine hesitancy. Statically significant associations were found between vaccine acceptance and age (p = .002) and gender (p = .03). Our study revealed a high prevalence of COVID-19 vaccine hesitancy (38.2%). Several sociodemographic characteristics were related to hesitancy, which may hinder the promotion of vaccine uptake. Public health campaigns is recommended to promote COVID-19 vaccine uptake.

Keywords